CTRI/2026/07/113622进行中（未招募）不适用
Plasma concentrations of generic posaconazole tablets used as Prophylaxis against invasive fungal infections: A prospective study - NIL
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients admitted under hematology taking posaconazole for prophylaxis against invasive fungal infections
- •Giving written informed consent and assent for the age group 12 to 14 years
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A Study to Assess the Effectiveness of Posaconazole 300 mg in Patients with Weak Immune SystemsCTRI/2025/02/081462Bajaj Healthcare Limited25
进行中（未招募）
不适用
Study of posaconazole blood levels comparing two different oral presentations, a syrup and a solid tablet, in patients with leukaemia at a high risk of fungal infectionsInvasive MycosesEUCTR2015-003940-38-ESFundación Investigación Biomédica Puerta de Hierro
已完成
4 期
Pharmacokinetics of posaconazole given as a single intravenous dose to obese subjects: Dosing Obese with Noxafil® Under a Trial (DONUT).NL-OMON45475Radboud Universitair Medisch Centrum26
已完成
4 期
Dosing Obese With Noxafil® Under a Trial (DONUT)Morbid ObesityNCT03246386Radboud University Medical Center24
进行中（未招募）
1 期
Monitoring of serum concentrations of posaconazole given as prophylaxis or therapy.MedDRA version: 9.1Level: LLTClassification code 10017533Term: Fungal infectionfungal infectionEUCTR2008-007712-14-BEErasme Hospital40